133 related articles for article (PubMed ID: 9865327)
1. Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
Kuttler B; Mathieu C; Bulfone-Paus S; Bouillon R; Diamantstein T; Hahn HJ
Transplant Proc; 1998 Dec; 30(8):4140-2. PubMed ID: 9865327
[No Abstract] [Full Text] [Related]
2. Interleukin 2 receptor-targeted therapy in islet transplantation research.
Hahn HJ; Kuttler B; Volk HD; Lucke S; Diamantstein T
Horm Metab Res Suppl; 1990; 25():177-80. PubMed ID: 2088963
[No Abstract] [Full Text] [Related]
3. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
[TBL] [Abstract][Full Text] [Related]
4. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
[TBL] [Abstract][Full Text] [Related]
5. Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.
Hahn HJ; Kuttler B; Lucke S; Dunger A; Besch W; Volk HD; Diamankstein T
Transplant Proc; 1989 Feb; 21(1 Pt 3):2711-3. PubMed ID: 2495678
[No Abstract] [Full Text] [Related]
6. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
7. Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
Hahn HJ; Kuttler B; Dunger A; Lucke S; Volk HD; Diamantstein T
Transplant Proc; 1991 Feb; 23(1 Pt 1):741-2. PubMed ID: 1990673
[No Abstract] [Full Text] [Related]
8. Effect of anti-interleukin-2 receptor antibody treatment on recurrent autoimmune insulitis in the BB rat.
Woehrle M; Pullmann J; Stuenkel KG; Bretzel RG; Federlin K
Transplant Proc; 1994 Apr; 26(2):734-5. PubMed ID: 8171631
[No Abstract] [Full Text] [Related]
9. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts.
Gysemans CA; Waer M; Valckx D; Laureys JM; Mihkalsky D; Bouillon R; Mathieu C
Diabetes; 2000 Dec; 49(12):1992-7. PubMed ID: 11117999
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
[TBL] [Abstract][Full Text] [Related]
11. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
Hahn HJ; Kauert C; Dunger A; Kuttler B; Diamantstein T
Autoimmunity; 1989; 5(1-2):139-42. PubMed ID: 2519014
[No Abstract] [Full Text] [Related]
14. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats.
Kuttler B; Rösing K; Hahn HJ
Transplant Proc; 1997 Jun; 29(4):2163-5. PubMed ID: 9193572
[No Abstract] [Full Text] [Related]
16. [The effects of NKG2D mAb on the survival of allogeneic transplanted islets in spontaneous diabetic nonobese diabetic mice].
Pan H; Lu YR; Zhang ZD; Jin X; Wei LL; Yuan Y; Lu HM; Mai G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):836-9, 848. PubMed ID: 21302453
[TBL] [Abstract][Full Text] [Related]
17. Encapsulated islet iso-, allo-, and xenografts in diabetic NOD mice.
Weber CJ; Hagler M; Konieczny B; Chryssochoos J; Rajotte R; Lakkis F; Lowry R
Transplant Proc; 1995 Dec; 27(6):3308-11. PubMed ID: 8539965
[No Abstract] [Full Text] [Related]
18. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats.
Fritschy WM; de Vos P; Groen H; Klatter FA; Pasma A; Wolters GH; van Schilfgaarde R
Transpl Int; 1994 Jul; 7(4):264-71. PubMed ID: 7916926
[TBL] [Abstract][Full Text] [Related]
19. Islet graft primary nonfunction and its prevention.
Arita S; Smith CV; Nagai T; Sakamoto Y; Maruyama M; Mullen Y
Transplant Proc; 2000 Nov; 32(7):1667. PubMed ID: 11119883
[No Abstract] [Full Text] [Related]
20. The syngeneic islet transplantation to study physiology and pathophysiology of pancreatic beta-cells.
Hahn HJ; Kuttler B
Adv Exp Med Biol; 1997; 426():411-9. PubMed ID: 9544301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
